Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma - Report - MDSpire

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma

  • By

  • Rafail C. Christodoulou

  • Revati Natu

  • Georgios Vamvouras

  • Platon S. Papageorgiou

  • Evros Vassiliou

  • Elena E. Solomou

  • Sokratis G. Papageorgiou

  • Michalis F. Georgiou

  • June 19, 2026

  • 0 min

Share

Clinical Report: Incremental Value Assessment of MRI for Predicting ATRX Status

Overview

This study evaluates the incremental value of apparent diffusion coefficient (ADC) and arterial spin labeling (ASL) radiomics in predicting ATRX status in glioblastoma (GBM).

Background

ATRX mutations are significant in glioblastoma, influencing tumor biology and treatment response. Noninvasive methods for predicting ATRX status could enhance risk stratification. This study explores the utility of advanced MRI techniques in providing insights into ATRX status, which is traditionally assessed through invasive tissue sampling.

Data Highlights

ModelROC-AUCPR-AUCSensitivity
Structural Model0.7210.3220.737
Model 1A (with ADC and ASL)0.7530.3640.947

Key Findings

  • ATRX mutations are linked to tumor heterogeneity and treatment response in GBM.
  • The best structural model achieved an ROC-AUC of 0.721.
  • Model 1A, incorporating ADC and ASL features, improved ROC-AUC to 0.753.
  • Model 1A demonstrated a sensitivity of 0.947, indicating high predictive capability.
  • ADC and ASL features contributed significant physiologic information in predicting ATRX status.

Clinical Implications

Incorporating ADC and ASL radiomics into MRI assessments may enhance the noninvasive prediction of ATRX status in GBM.

Conclusion

The study supports the use of advanced MRI techniques as complementary tools for predicting ATRX status in glioblastoma.

Related Resources & Content

  1. Journal of Neuro-Oncology, 2025 -- Imaging Analysis of Post-Chemoradiation Glioblastoma Based on Diffusion MRI Phenotypes Linked to Positive Anti-VEGF Treatment Outcomes
  2. European Radiology, 2023 -- Differentiating Atypical Primary Central Nervous System Lymphoma from Glioblastoma Using Multiparametric MRI Techniques: Analyzing Non-Enhancing Volume, Apparent Diffusion Coefficient, and Arterial Spin Labeling
  3. European Radiology, 2023 -- Development and Validation of a Radiomics Model Utilizing Multiple Diffusion MRI Features to Predict Grades of Adult-Type Diffuse Gliomas
  4. European Radiology, 2023 -- Concurrent Assessment of Cerebral Blood Flow, Vascular Permeability, and Leakage in Gliomas via Dynamic Spin-and-Gradient-Echo Echoplanar Imaging MRI
  5. The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas
  6. Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection—Update 1 | Neuro-Oncology | Oxford Academic
  7. ACR Appropriateness Criteria for Brain Tumors
  8. The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas
  9. Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection—Update 1 | Neuro-Oncology | Oxford Academic

Original Source(s)

Related Content